 ACTON, Mass.--BUSINESS WIRE--Insulet Corporation NASDAQ: PODD Insulet or the Company, the global leader in tubeless insulin pump technology with its Omnipod brand of products, has presented positive pivotal trial extension phase results for the Omnipod 5 Automated Insulin Delivery System Omnipod 5. Omnipod 5, the worlds first tubeless, wearable system that continuously adapts insulin delivery based on glucose levels and trends, significantly improved time in range and reduced HbA1c i 